IN188469B - - Google Patents

Info

Publication number
IN188469B
IN188469B IN420DE2000A IN188469B IN 188469 B IN188469 B IN 188469B IN 420DE2000 A IN420DE2000 A IN 420DE2000A IN 188469 B IN188469 B IN 188469B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Herve Bouchard
Alain Commercon
Original Assignee
Rohne Poulenc Rorer S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohne Poulenc Rorer S A filed Critical Rohne Poulenc Rorer S A
Publication of IN188469B publication Critical patent/IN188469B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN420DE2000 1995-12-22 2000-04-10 IN188469B (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
IN188469B true IN188469B (cg-RX-API-DMAC10.html) 2002-09-28

Family

ID=9485871

Family Applications (4)

Application Number Title Priority Date Filing Date
IN2893DE1996 IN186768B (cg-RX-API-DMAC10.html) 1995-12-22 1996-12-20
IN420DE2000 IN188469B (cg-RX-API-DMAC10.html) 1995-12-22 2000-04-10
IN419DE2000 IN188680B (cg-RX-API-DMAC10.html) 1995-12-22 2000-04-10
IN421DE2000 IN188470B (cg-RX-API-DMAC10.html) 1995-12-22 2000-04-10

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IN2893DE1996 IN186768B (cg-RX-API-DMAC10.html) 1995-12-22 1996-12-20

Family Applications After (2)

Application Number Title Priority Date Filing Date
IN419DE2000 IN188680B (cg-RX-API-DMAC10.html) 1995-12-22 2000-04-10
IN421DE2000 IN188470B (cg-RX-API-DMAC10.html) 1995-12-22 2000-04-10

Country Status (40)

Country Link
US (1) US5728849A (cg-RX-API-DMAC10.html)
EP (1) EP0876362B1 (cg-RX-API-DMAC10.html)
JP (1) JP3953106B2 (cg-RX-API-DMAC10.html)
KR (1) KR100500351B1 (cg-RX-API-DMAC10.html)
CN (1) CN1103766C (cg-RX-API-DMAC10.html)
AR (1) AR005197A1 (cg-RX-API-DMAC10.html)
AT (1) ATE250593T1 (cg-RX-API-DMAC10.html)
AU (1) AU712597B2 (cg-RX-API-DMAC10.html)
BG (1) BG63204B1 (cg-RX-API-DMAC10.html)
BR (1) BR9612135A (cg-RX-API-DMAC10.html)
CA (1) CA2238884C (cg-RX-API-DMAC10.html)
CO (1) CO4520184A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ294972B6 (cg-RX-API-DMAC10.html)
DE (1) DE69630145T2 (cg-RX-API-DMAC10.html)
DK (1) DK0876362T3 (cg-RX-API-DMAC10.html)
DZ (1) DZ2149A1 (cg-RX-API-DMAC10.html)
EA (1) EA001533B1 (cg-RX-API-DMAC10.html)
ES (1) ES2202490T3 (cg-RX-API-DMAC10.html)
FR (1) FR2742751B1 (cg-RX-API-DMAC10.html)
HU (1) HU225032B1 (cg-RX-API-DMAC10.html)
IL (1) IL124994A (cg-RX-API-DMAC10.html)
IN (4) IN186768B (cg-RX-API-DMAC10.html)
MA (1) MA26412A1 (cg-RX-API-DMAC10.html)
MX (1) MX9804688A (cg-RX-API-DMAC10.html)
MY (1) MY113934A (cg-RX-API-DMAC10.html)
NO (1) NO317358B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ324337A (cg-RX-API-DMAC10.html)
OA (1) OA10700A (cg-RX-API-DMAC10.html)
PE (1) PE25198A1 (cg-RX-API-DMAC10.html)
PL (1) PL189311B1 (cg-RX-API-DMAC10.html)
PT (1) PT876362E (cg-RX-API-DMAC10.html)
RO (1) RO116194B1 (cg-RX-API-DMAC10.html)
SK (1) SK282835B6 (cg-RX-API-DMAC10.html)
TN (1) TNSN96169A1 (cg-RX-API-DMAC10.html)
TR (1) TR199801179T2 (cg-RX-API-DMAC10.html)
TW (1) TW371659B (cg-RX-API-DMAC10.html)
UA (1) UA48205C2 (cg-RX-API-DMAC10.html)
UY (1) UY24386A1 (cg-RX-API-DMAC10.html)
WO (1) WO1997023473A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA9610737B (cg-RX-API-DMAC10.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
CZ20013405A3 (cs) 2000-02-02 2002-03-13 Florida State University Research Foundation, Inc. C10 karbonátem substituované taxany jako protinádorová činidla
SK286975B6 (sk) * 2001-02-24 2009-08-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xantínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US20080107721A1 (en) * 2003-05-20 2008-05-08 Jonathan Lewis Combination Chemotherapy Comprising A Liposomal Platinum Complex
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) * 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
KR101541791B1 (ko) * 2006-05-04 2015-08-04 베링거 인겔하임 인터내셔날 게엠베하 다형태
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
AU2008290582B2 (en) * 2007-08-17 2014-08-14 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
US20110190322A1 (en) * 2008-08-14 2011-08-04 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
BRPI0919288A2 (pt) 2008-09-10 2015-12-15 Boehring Ingelheim Internat Gmbh teriapia de combinação para tratamento de diabetes e condições relacionadas.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
KR20110103968A (ko) 2008-12-23 2011-09-21 베링거 인겔하임 인터내셔날 게엠베하 유기 화합물의 염 형태
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
KR20240090632A (ko) 2009-11-27 2024-06-21 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
ES2935300T3 (es) 2010-05-05 2023-03-03 Boehringer Ingelheim Int Combiterapia
MX2012014247A (es) 2010-06-24 2013-01-18 Boehringer Ingelheim Int Terapia para la diabetes.
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
ES2934843T3 (es) 2011-07-15 2023-02-27 Boehringer Ingelheim Int Derivado de quinazolina dimérico sustituido, su preparación y su uso en composiciones farmacéuticas para el tratamiento de la diabetes de tipo I y II
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
EP4151218A1 (en) 2012-05-14 2023-03-22 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
CA2891280C (en) 2012-11-24 2018-03-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
US10464955B2 (en) 2014-02-28 2019-11-05 Hangzhou Dac Biotech Co., Ltd. Charged linkers and their uses for conjugation
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
EP4678240A2 (en) 2015-07-12 2026-01-14 Hangzhou Dac Biotech Co., Ltd. Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin
MX2019005583A (es) 2016-11-14 2019-10-21 Hangzhou Dac Biotech Co Ltd Vinculantes de conjugacion, conjugados de molecula de union a celulas que contienen los vinculantes, metodos de creacion y usos de dichos conjugados con los vinculantes.
EP4426727A2 (en) 2021-11-03 2024-09-11 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
AU672006B2 (en) * 1992-04-17 1996-09-19 Abbott Laboratories Taxol derivatives
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.

Also Published As

Publication number Publication date
ES2202490T3 (es) 2004-04-01
EA001533B1 (ru) 2001-04-23
CA2238884C (fr) 2007-02-06
BR9612135A (pt) 1999-07-13
NO982580L (no) 1998-06-05
CA2238884A1 (fr) 1997-07-03
IN188680B (cg-RX-API-DMAC10.html) 2002-10-26
DE69630145D1 (de) 2003-10-30
IL124994A (en) 2000-12-06
BG63204B1 (bg) 2001-06-29
EP0876362A1 (fr) 1998-11-11
HUP9904046A1 (hu) 2001-04-28
ATE250593T1 (de) 2003-10-15
NZ324337A (en) 2000-03-27
MA26412A1 (fr) 2004-12-20
AU712597B2 (en) 1999-11-11
AR005197A1 (es) 1999-04-14
NO982580D0 (no) 1998-06-05
PL327405A1 (en) 1998-12-07
FR2742751A1 (fr) 1997-06-27
SK85398A3 (en) 1998-11-04
TW371659B (en) 1999-10-11
MY113934A (en) 2002-06-29
BG102569A (en) 1999-04-30
KR19990076680A (ko) 1999-10-15
IN186768B (cg-RX-API-DMAC10.html) 2001-11-03
MX9804688A (es) 1998-10-31
ZA9610737B (en) 1997-06-27
DE69630145T2 (de) 2004-07-15
PE25198A1 (es) 1998-05-10
DK0876362T3 (da) 2004-02-02
UA48205C2 (uk) 2002-08-15
RO116194B1 (ro) 2000-11-30
OA10700A (fr) 2002-11-27
US5728849A (en) 1998-03-17
EP0876362B1 (fr) 2003-09-24
EA199800588A1 (ru) 1998-12-24
IL124994A0 (en) 1999-01-26
IN188470B (cg-RX-API-DMAC10.html) 2002-09-28
KR100500351B1 (ko) 2005-12-21
CZ294972B6 (cs) 2005-04-13
HK1017895A1 (en) 1999-12-03
NO317358B1 (no) 2004-10-18
TNSN96169A1 (fr) 2005-03-15
PL189311B1 (pl) 2005-07-29
HUP9904046A3 (en) 2001-08-28
PT876362E (pt) 2004-02-27
UY24386A1 (es) 2001-08-27
JP2000502671A (ja) 2000-03-07
WO1997023473A1 (fr) 1997-07-03
CN1103766C (zh) 2003-03-26
SK282835B6 (sk) 2002-12-03
HU225032B1 (en) 2006-05-29
CN1205697A (zh) 1999-01-20
DZ2149A1 (fr) 2002-10-23
JP3953106B2 (ja) 2007-08-08
FR2742751B1 (fr) 1998-01-30
CZ196198A3 (cs) 1998-09-16
TR199801179T2 (xx) 1998-10-21
CO4520184A1 (es) 1997-10-15
AU1180997A (en) 1997-07-17

Similar Documents

Publication Publication Date Title
BR122012014331A2 (cg-RX-API-DMAC10.html)
BRPI9612258B1 (cg-RX-API-DMAC10.html)
BRPI9612138B1 (cg-RX-API-DMAC10.html)
IN188469B (cg-RX-API-DMAC10.html)
CH0741373H1 (cg-RX-API-DMAC10.html)
BR7501503U (cg-RX-API-DMAC10.html)
BR7502120U (cg-RX-API-DMAC10.html)
CN3032332S (cg-RX-API-DMAC10.html)
CN3033225S (cg-RX-API-DMAC10.html)
CN3030154S (cg-RX-API-DMAC10.html)
CN3030197S (cg-RX-API-DMAC10.html)
CN3030225S (cg-RX-API-DMAC10.html)
CN3030296S (cg-RX-API-DMAC10.html)
CN3030415S (cg-RX-API-DMAC10.html)
CN3030489S (cg-RX-API-DMAC10.html)
CN3030542S (cg-RX-API-DMAC10.html)
CN3030543S (cg-RX-API-DMAC10.html)
CN3030760S (cg-RX-API-DMAC10.html)
CN3031001S (cg-RX-API-DMAC10.html)
CN3031350S (cg-RX-API-DMAC10.html)
CN3031655S (cg-RX-API-DMAC10.html)
CN3031742S (cg-RX-API-DMAC10.html)
CN3031926S (cg-RX-API-DMAC10.html)
CN3029801S (cg-RX-API-DMAC10.html)
CN3032390S (cg-RX-API-DMAC10.html)